{
    "2021-10-28": [
        [
            {
                "time": "2021-10-31",
                "original_text": "华大基因子公司无创产前基因检测相关产品获得印度进口许可证",
                "features": {
                    "keywords": [
                        "华大基因",
                        "子公司",
                        "无创产前基因检测",
                        "印度进口许可证"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-10-31",
                "original_text": "华大基因三季度业绩双降，拟以不超2.6亿元回购股份",
                "features": {
                    "keywords": [
                        "华大基因",
                        "三季度",
                        "业绩双降",
                        "回购股份"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-10-31",
                "original_text": "华大基因发布回购公告，拟回购总额1.3亿元-2.6亿元",
                "features": {
                    "keywords": [
                        "华大基因",
                        "回购公告",
                        "回购总额"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-10-31",
                "original_text": "华大基因三季度业绩双降：净利润下滑68.86%，拟以不超2.6亿元回购股份",
                "features": {
                    "keywords": [
                        "华大基因",
                        "三季度",
                        "业绩双降",
                        "净利润下滑",
                        "回购股份"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-10-31",
                "original_text": "华大基因公布三季报，回购公司股份方案出炉",
                "features": {
                    "keywords": [
                        "华大基因",
                        "三季报",
                        "回购股份"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-10-31",
                "original_text": "华大基因前三季度营收、净利双降",
                "features": {
                    "keywords": [
                        "华大基因",
                        "前三季",
                        "营收",
                        "净利双降"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-10-31",
                "original_text": "图解华大基因三季报：第三季度单季净利润同比减68.86%",
                "features": {
                    "keywords": [
                        "华大基因",
                        "三季报",
                        "单季净利润",
                        "同比减"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-10-31",
                "original_text": "新鲜出炉！华大基因：2021年第三季度净利润约3.28亿元，同比下降68.86%",
                "features": {
                    "keywords": [
                        "华大基因",
                        "2021年",
                        "第三季度",
                        "净利润",
                        "同比下降"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-10-31",
                "original_text": "华大基因：第三季度净利同比下降68.86%",
                "features": {
                    "keywords": [
                        "华大基因",
                        "第三季度",
                        "净利",
                        "同比下降"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-10-31",
                "original_text": "华大基因：1.3亿元至2.6亿元回购股份",
                "features": {
                    "keywords": [
                        "华大基因",
                        "回购股份",
                        "1.3亿元至2.6亿元"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-10-31",
                "original_text": "华大基因：第三季度净利3.28亿元 同比下降68.86%",
                "features": {
                    "keywords": [
                        "华大基因",
                        "第三季度",
                        "净利",
                        "同比下降"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-10-31",
                "original_text": "华大基因：前三季度净利润同比减少47.72% 盈利能力下降",
                "features": {
                    "keywords": [
                        "华大基因",
                        "前三季度",
                        "净利润",
                        "同比减少",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}